Adherence to statins and LDL-cholesterol goal attainment

American Journal of Managed Care

Volumn 20, Issue 4, 2014, Pages

  Chi, Margaret D ^a   Vansomphone, Southida S ^b   Liu, In Lu Amy ^a   Cheetham, T Craig ^b   Green, Kelley R ^b   Scott, Ronald D ^b   Reynolds, Kristi ^a  

^a Department of Research and Evaluation Kaiser Permanente Southern California ^*  (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ETHNICITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; AGE; AGED; BLOOD; CARDIOVASCULAR DISEASES; DRUG EFFECTS; FEMALE; MEDICATION COMPLIANCE; MIDDLE AGED; REGISTER; RISK ASSESSMENT; SEX DIFFERENCE; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGE FACTORS; AGED; ANTICHOLESTEREMIC AGENTS; CALIFORNIA; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; REGISTRIES; RISK ASSESSMENT; SEX FACTORS;

EID: 84903374315     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6-e245.
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25-e146.
3. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004; 164(13):1427-1436. (Pubitemid 38937854)
4. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart. 2002;88(3):229-233. (Pubitemid 34913500)
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
6. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(25):3143-3421.
7. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008;52(22):1769-1781.
8. Nishiwaki T, Kishi D, Yoshie F, et al. Relationship between LDL-C reduction after coronary revascularization and prevention of recurrence of cardiovascular events. J Pharm Pharm Sci. 2010;13(2):254-262.
9. Smith SC, Jr., Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47(10):2130-2139. (Pubitemid 44275145)
10. Chodick G, Shalev V, Gerber Y, et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin Ther. 2008; 30(11):2167-2179.
11. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-461. (Pubitemid 34787476)
12. Goldman DP, Joyce GF, Karaca-Mandic P. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. Am J Manag Care. 2006;12(1):21-28. (Pubitemid 43139537)
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
14. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772-779. (Pubitemid 351410514)
15. Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10): 1153-1158.
16. Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2006;6:48.
17. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203-212.
18. Nag SS, Daniel GW, Bullano MF, et al. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO. J Manag Care Pharm. 2007;13(8):652-663. (Pubitemid 350065234)
19. Benner JS, Pollack MF, Smith TW, Bullano MF, Willey VJ, Williams SA. Association between short-term effectiveness of statins and longterm adherence to lipid-lowering therapy. Am J Health Syst Pharm. 2005;62(14):1468-1475. (Pubitemid 41008860)
20. Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132(11):926-930. (Pubitemid 30346866)
21. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25(9):2303-2310.
22. Steiner JF, Ho PM, Beaty BL, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009;2(5): 451-457.
23. Wu JR, Moser DK, De Jong MJ, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J. 2009;157(2): 285-291.
24. Dudl RJ, Wang MC, Wong M, Bellows J. Preventing myocardial infarction and stroke with a simplified bundle of cardioprotective medications. Am J Manag Care. 2009;15(10):e88-e94.
25. Rozario PA, Morrow-Howell N, Proctor E. Comparing the congruency of self-report and provider records of depressed elders' service use by provider type. Med Care. 2004;42(10):952-959. (Pubitemid 39530790)
26. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497. (Pubitemid 41127293)
27. Koebnick C, Langer-Gould AM, Gould MK, et al. Sociodemographic characteristics of members of a large, integrated healthcare system: comparison with US Census Bureau data. Perm J. 2012;16(3):37-41.